GPT and neutropenia: The incidence of adverse events included the following: neutropenia (n = 4, 10.8%); fatigue (n = 3, 7.9%); hypothyroidism (n = 2, 5.3%); thrombocytopenia (n = 2, 5.3%); and elevated serum alanine aminotransferase or aspartate aminotransferase (n = 2, 5.3%).